what are the risks of glp 1 drugs GLP-1 and Eating Disorders: A Hidden Risk in Weight Loss Revolution – The Chicago Council on Science and Technology GLP 1 Blindness Risk |

Pharmacologic Overview of GLP-1 Receptor Agonists Mechanism of Action Endogenous GLP-1 is an incretin hormone secreted by intestinal L-cells postprandially

The patient who expects a targeted, evidence-based intervention that works best alongside other clinical and lifestyle inputs is working from the actual clinical picture

It supports immune function, detoxification pathways, and cellular repair mechanisms

Patients and healthcare professionals are encouraged to report any suspected side effects via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk or via the Yellow Card app

While some individuals may observe noticeable changes in skin tone and texture after consistent use of glutathione injections, others might experience more subtle or minimal effects

doi: 10.1016/j.jep.2014.09.049 261